Table of Contents
What changed
Revenue rose 27.9% to $6.8m, but the headline loss widened from $5.3m to $5.7m, a further 7.5% deterioration in both PBT and NPAT (no tax was booked in either year, so the two lines are identical). The defining move was on the balance sheet: gross borrowings fell from $33.0m to zero, cash rose from $3.7m to $10.9m, and the group shifted from $29.2m net debt to $10.9m net cash following the settlement of 35 Graham Street. Total assets contracted 38.0% to $118.0m and equity fell 16.9% to $117.4m, reflecting both the disposal and the accumulated loss. Operating cash flow swung from a $0.4m inflow to a $0.1m outflow.
What matters
- Balance sheet reset is the clearest positive. Full debt repayment, a $10.9m cash balance and a move to net cash materially de-risks the vehicle and removes the interest drag that had been a stated headwind in FY24.
- H2 profitability collapsed. HY25 printed a $2.3m profit, implying a second-half NPAT of roughly –$8.0m. The HY25 result benefited from items tied to the Graham Street transaction; the underlying earnings base left after the sale is visibly thinner than the interim shape suggested.
- Capital allocation is now in flux. A 5 cent special dividend was paid in December 2024, and the release flags a quarterly dividend regime "subject to quarterly review", with future leasing costs and incentives to be funded from operating cash. That is a softer framing than a committed payout.
Expectations
No explicit forward targets, forward-work backlog, or guidance figures were supplied. The release does, however, signal that operating profits are now expected to cover leasing costs and incentives, and that further dividends will be reviewed quarterly. HY25 contributed 47.5% of full-year revenue, so the revenue shape is close to even, but the –40.8% HY25 share of full-year NPAT confirms the profit weighting is severely back-end loaded in the wrong direction. The filing supports the claim that leverage has been addressed; it does not yet support a claim that run-rate earnings cover the dividend.
Quality of result
Low durability. Revenue growth is genuine but off a small base ($6.8m), and the core earnings line remained a loss even before tax. Operating cash flow deteriorated by $0.6m year-on-year to a $0.1m outflow, so cash conversion weakened materially despite the reported revenue uplift. Pre-lease free cash flow was –$0.3m; the $7.2m cash build is an investing-activities outcome from the asset sale, not an operating result. Capex fell from $6.5m to $0.1m, which flatters the cash movement but also signals a far smaller investment programme post-disposal. With only $24k of trade receivables there is no receivables tailwind to unwind, but equally no working-capital cushion to flag.
Quality of result caveat on capital returns
The December 2024 5 cps special dividend and any subsequent quarterly dividends are being funded from sale proceeds and retained cash, not from FY25 free cash flow, which was negative. Distributions are therefore a balance-sheet distribution rather than an earnings distribution on this year's numbers.
Unresolved
- What is the true post-disposal run-rate: with Graham Street gone, what does the remaining portfolio's steady-state rental income and operating surplus look like on a full-year basis?
- What drove the H2 swing from a $2.3m H1 profit to an implied $8.0m H2 loss — revaluations, transaction-related items, or operating deterioration? The supplied excerpts do not isolate it.
- How sustainable is the "quarterly review" dividend if operating cash flow remains around breakeven and capex needs rise with leasing activity at Munroe Lane and other assets?
- Is there tenant or asset concentration risk in the residual portfolio? None was disclosed in the supplied excerpts.
This briefing cannot assess portfolio-level valuation movements, tenancy metrics, or the composition of the H2 loss, because segment, revaluation and fair-value detail were not included in the supplied extraction.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $6.8m | $5.3m | +27.9% ↑ |
| Net profit after tax | −$5.7m | −$5.3m | -7.5% ↓ |
| Net cash inflow from operating activities | −$0.1m | $0.4m | -131.6% ↓ |
| Final dividend per share | 32.4c | — | — |
| Cash and cash equivalents | $10.9m | $3.7m | +192.6% ↑ |
| Total assets | $118.0m | $190.3m | -38.0% ↓ |
Reference: annolyse.ai/briefings/apl-fy25
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| FCF pre-lease | −$0.3m | −$6.1m | +$5.8m |
| FCF post-lease | −$0.3m | −$6.1m | +$5.8m |
| FCF / NPAT | 4.8% | 115.0% | complementary conversion metric |
| Capex % revenue | 2.0% | 122.5% | — |
| Capex | −$0.1m | −$6.5m | +$6.4m |
| Debtor days | 1.3 | 0.0 | +1.3 days |
| Trade debtors | $0.0m | $0.0m | +$0.0m |
| Net debt | −$10.9m | $29.2m | −$40.2m |
| Gross borrowings | $0.0m | $33.0m | −$33.0m |
| ROE (annualised) | -4.9% | -3.7% | Weakening |
| HY25 share of FY25 revenue | 47.5% | — | Other half was 52.5% |
| HY25 share of FY25 NPAT | -40.8% | — | Other half was 140.8% |
| Profit from continuing operations | — | −$5.3m | — |
Reference: annolyse.ai/briefings/apl-fy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.